Cargando…
Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease mainly affecting upper and lower motoneurons. Several functionally heterogeneous genes have been associated with the familial form of this disorder (fALS), depicting an extremely complex pathogenic landscape. This heterogeneity...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412488/ https://www.ncbi.nlm.nih.gov/pubmed/37488208 http://dx.doi.org/10.1007/s00401-023-02611-y |
_version_ | 1785086917836013568 |
---|---|
author | Aly, Amr Laszlo, Zsofia I. Rajkumar, Sandeep Demir, Tugba Hindley, Nicole Lamont, Douglas J. Lehmann, Johannes Seidel, Mira Sommer, Daniel Franz-Wachtel, Mirita Barletta, Francesca Heumos, Simon Czemmel, Stefan Kabashi, Edor Ludolph, Albert Boeckers, Tobias M. Henstridge, Christopher M. Catanese, Alberto |
author_facet | Aly, Amr Laszlo, Zsofia I. Rajkumar, Sandeep Demir, Tugba Hindley, Nicole Lamont, Douglas J. Lehmann, Johannes Seidel, Mira Sommer, Daniel Franz-Wachtel, Mirita Barletta, Francesca Heumos, Simon Czemmel, Stefan Kabashi, Edor Ludolph, Albert Boeckers, Tobias M. Henstridge, Christopher M. Catanese, Alberto |
author_sort | Aly, Amr |
collection | PubMed |
description | Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease mainly affecting upper and lower motoneurons. Several functionally heterogeneous genes have been associated with the familial form of this disorder (fALS), depicting an extremely complex pathogenic landscape. This heterogeneity has limited the identification of an effective therapy, and this bleak prognosis will only improve with a greater understanding of convergent disease mechanisms. Recent evidence from human post-mortem material and diverse model systems has highlighted the synapse as a crucial structure actively involved in disease progression, suggesting that synaptic aberrations might represent a shared pathological feature across the ALS spectrum. To test this hypothesis, we performed the first comprehensive analysis of the synaptic proteome from post-mortem spinal cord and human iPSC-derived motoneurons carrying mutations in the major ALS genes. This integrated approach highlighted perturbations in the molecular machinery controlling vesicle release as a shared pathomechanism in ALS. Mechanistically, phosphoproteomic analysis linked the presynaptic vesicular phenotype to an accumulation of cytotoxic protein aggregates and to the pro-apoptotic activation of the transcription factor c-Jun, providing detailed insights into the shared pathobiochemistry in ALS. Notably, sub-chronic treatment of our iPSC-derived motoneurons with the fatty acid docosahexaenoic acid exerted a neuroprotective effect by efficiently rescuing the alterations revealed by our multidisciplinary approach. Together, this study provides strong evidence for the central and convergent role played by the synaptic microenvironment within the ALS spinal cord and highlights a potential therapeutic target that counteracts degeneration in a heterogeneous cohort of human motoneuron cultures. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00401-023-02611-y. |
format | Online Article Text |
id | pubmed-10412488 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-104124882023-08-11 Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS Aly, Amr Laszlo, Zsofia I. Rajkumar, Sandeep Demir, Tugba Hindley, Nicole Lamont, Douglas J. Lehmann, Johannes Seidel, Mira Sommer, Daniel Franz-Wachtel, Mirita Barletta, Francesca Heumos, Simon Czemmel, Stefan Kabashi, Edor Ludolph, Albert Boeckers, Tobias M. Henstridge, Christopher M. Catanese, Alberto Acta Neuropathol Original Paper Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease mainly affecting upper and lower motoneurons. Several functionally heterogeneous genes have been associated with the familial form of this disorder (fALS), depicting an extremely complex pathogenic landscape. This heterogeneity has limited the identification of an effective therapy, and this bleak prognosis will only improve with a greater understanding of convergent disease mechanisms. Recent evidence from human post-mortem material and diverse model systems has highlighted the synapse as a crucial structure actively involved in disease progression, suggesting that synaptic aberrations might represent a shared pathological feature across the ALS spectrum. To test this hypothesis, we performed the first comprehensive analysis of the synaptic proteome from post-mortem spinal cord and human iPSC-derived motoneurons carrying mutations in the major ALS genes. This integrated approach highlighted perturbations in the molecular machinery controlling vesicle release as a shared pathomechanism in ALS. Mechanistically, phosphoproteomic analysis linked the presynaptic vesicular phenotype to an accumulation of cytotoxic protein aggregates and to the pro-apoptotic activation of the transcription factor c-Jun, providing detailed insights into the shared pathobiochemistry in ALS. Notably, sub-chronic treatment of our iPSC-derived motoneurons with the fatty acid docosahexaenoic acid exerted a neuroprotective effect by efficiently rescuing the alterations revealed by our multidisciplinary approach. Together, this study provides strong evidence for the central and convergent role played by the synaptic microenvironment within the ALS spinal cord and highlights a potential therapeutic target that counteracts degeneration in a heterogeneous cohort of human motoneuron cultures. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00401-023-02611-y. Springer Berlin Heidelberg 2023-07-24 2023 /pmc/articles/PMC10412488/ /pubmed/37488208 http://dx.doi.org/10.1007/s00401-023-02611-y Text en © The Author(s) 2023, corrected publication 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Paper Aly, Amr Laszlo, Zsofia I. Rajkumar, Sandeep Demir, Tugba Hindley, Nicole Lamont, Douglas J. Lehmann, Johannes Seidel, Mira Sommer, Daniel Franz-Wachtel, Mirita Barletta, Francesca Heumos, Simon Czemmel, Stefan Kabashi, Edor Ludolph, Albert Boeckers, Tobias M. Henstridge, Christopher M. Catanese, Alberto Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS |
title | Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS |
title_full | Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS |
title_fullStr | Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS |
title_full_unstemmed | Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS |
title_short | Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS |
title_sort | integrative proteomics highlight presynaptic alterations and c-jun misactivation as convergent pathomechanisms in als |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412488/ https://www.ncbi.nlm.nih.gov/pubmed/37488208 http://dx.doi.org/10.1007/s00401-023-02611-y |
work_keys_str_mv | AT alyamr integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals AT laszlozsofiai integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals AT rajkumarsandeep integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals AT demirtugba integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals AT hindleynicole integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals AT lamontdouglasj integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals AT lehmannjohannes integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals AT seidelmira integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals AT sommerdaniel integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals AT franzwachtelmirita integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals AT barlettafrancesca integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals AT heumossimon integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals AT czemmelstefan integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals AT kabashiedor integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals AT ludolphalbert integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals AT boeckerstobiasm integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals AT henstridgechristopherm integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals AT catanesealberto integrativeproteomicshighlightpresynapticalterationsandcjunmisactivationasconvergentpathomechanismsinals |